Skip to main content

Table 1 Baseline characteristics of the participants

From: Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)

Patient’s serial number

Date of symptom onset

Date of hospital admission

Date of ICU admission

Underlying disorders

Medications received before the onset of hemoperfusion

Vital signs before the first session of hemoperfusion

Date of hemoperfusion sessions

Body Temperature (°C)

Blood Pressure (mm/Hg)

Pulse Rate (per minute)

Respiratory Rate (per minute)

The 1st

The 2nd

The 3rd

1

2020-03-05

2020-03-10

2020-3-13

Single kidney and chronic kidney disease

Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75

36.2

131/70

67

24

2020-03-17

2020-03-19

2020-03-21

2

2020-03-05

2020-03-11

2020-03-14

Pneumoconiosis

Vancomycin, Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Oseltamivir 75

37.0

153/100

99

28

2020-03-17

2020-03-18

2020-03-20

3

2020-03-08

2020-03-11

2020-03-13

No

Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75

38.0

100/60

100

25

2020-03-18

2020-03-19

2020-03-20

4

2020-03-10

2020-03-14

2020-03-15

No

Vancomycin, Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75

37.5

112/80

80

23

2020-03-16

2020-03-17

2020-03-18

5

2020-03-10

2020-03-14

2020-03-15

No

Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Azithromycin, Hydroxychloroquine, Meropenem, Oseltamivir 75

37.0

130/75

85

40

2020-03-15

2020-03-16

2020-03-18

6

2020-03-10

2020-03-15

2020-03-17

No

Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem

37.7

143/88

93

22

2020-03-23

2020-03-24

2020-03-25

7

2020-03-10

2020-03-16

2020-03-19

Malignancy (Leukemia)

Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75

36.8

123/96

108

30

2020-03-21

2020-03-22

2020-03-23

8

2020-03-10

2020-03-16

2020-03-19

Cardiovascular disorders, Hypertension, Coronary artery bypass graft surgery, Diabetes mellitus, Parkinson, Rheumatoid arthritis

Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75

36.5

110/70

100

18

2020-03-20

2020-03-21

2020-03-22

9

2020-03-10

2020-03-17

Diabetes mellitus

Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Meropenem

37.7

110/70

91

35

2020-03-21

2020-03-22

2020-03-23

10

2020-03-20

2020-03-23

2020-03-27

Cardiovascular disorders, Hypertension, Diabetes mellitus, Chronic kidney disease

Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem

38.5

100/57

57

26

2020-03-26

2020-03-30

2020-04-01